Literature DB >> 23831156

MALDI mass spectrometry in prostate cancer biomarker discovery.

Brian Flatley1, Peter Malone2, Rainer Cramer3.   

Abstract

Matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry (MS) is a highly versatile and sensitive analytical technique, which is known for its soft ionisation of biomolecules such as peptides and proteins. Generally, MALDI MS analysis requires little sample preparation, and in some cases like MS profiling it can be automated through the use of robotic liquid-handling systems. For more than a decade now, MALDI MS has been extensively utilised in the search for biomarkers that could aid clinicians in diagnosis, prognosis, and treatment decision making. This review examines the various MALDI-based MS techniques like MS imaging, MS profiling and proteomics in-depth analysis where MALDI MS follows fractionation and separation methods such as gel electrophoresis, and how these have contributed to prostate cancer biomarker research. This article is part of a Special Issue entitled: Biomarkers: A Proteomic Challenge.
© 2013.

Entities:  

Keywords:  Biomarkers; MALDI MS; MS imaging; MS profiling; Prostate cancer

Mesh:

Substances:

Year:  2013        PMID: 23831156     DOI: 10.1016/j.bbapap.2013.06.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection.

Authors:  Heather E Hulme; Lynsey M Meikle; Hannah Wessel; Nicole Strittmatter; John Swales; Carolyn Thomson; Anna Nilsson; Robert J B Nibbs; Simon Milling; Per E Andren; C Logan Mackay; Alex Dexter; Josephine Bunch; Richard J A Goodwin; Richard Burchmore; Daniel M Wall
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

2.  Mass spectrometry and multivariate analysis to classify cervical intraepithelial neoplasia from blood plasma: an untargeted lipidomic study.

Authors:  Ana C O Neves; Camilo L M Morais; Thais P P Mendes; Boniek G Vaz; Kássio M G Lima
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

3.  MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers.

Authors:  Andrea Padoan; Daniela Basso; Carlo-Federico Zambon; Tommaso Prayer-Galetti; Giorgio Arrigoni; Dania Bozzato; Stefania Moz; Filiberto Zattoni; Rino Bellocco; Mario Plebani
Journal:  Clin Proteomics       Date:  2018-07-25       Impact factor: 3.988

Review 4.  Advances in MALDI Mass Spectrometry Imaging Single Cell and Tissues.

Authors:  Xiaoping Zhu; Tianyi Xu; Chen Peng; Shihua Wu
Journal:  Front Chem       Date:  2022-02-03       Impact factor: 5.221

5.  SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers.

Authors:  Adriana Albini; Daniela Briga; Matteo Conti; Antonino Bruno; Daniela Farioli; Sara Canali; Ilaria Sogno; Gioacchino D'Ambrosio; Paolo Consonni; Douglas M Noonan
Journal:  Rapid Commun Mass Spectrom       Date:  2015-10-15       Impact factor: 2.419

6.  Classification of cancer cell lines using matrix-assisted laser desorption/ionization time‑of‑flight mass spectrometry and statistical analysis.

Authors:  Vlad Serafim; Ajit Shah; Maria Puiu; Nicoleta Andreescu; Dorina Coricovac; Alexander Nosyrev; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Dehelean; Iulia Pinzaru
Journal:  Int J Mol Med       Date:  2017-07-27       Impact factor: 4.101

Review 7.  MALDI-TOF/MS Analysis of Non-Invasive Human Urine and Saliva Samples for the Identification of New Cancer Biomarkers.

Authors:  Carlo Zambonin; Antonella Aresta
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.